340 POSTER Anti-tumor activity of YM753, a histone deacetylase inhibitor, against hormone refractory prostate cancer

Authors :: M. Mori
K. Sohda
N. Amino
Y. Terada
Masao Sasamata
Y. Sowa
A. Kita
M. Taniguchi
T. Sakai
N. Shindoh
Source :: European Journal of Cancer Supplements. 6:108
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Antitumor activity
Cancer Research
Oncology
business.industry
medicine.drug_class
Histone deacetylase inhibitor
Cancer research
Medicine
business
Hormone refractory prostate cancer

Tools